Concepedia

Amrita Sule

AS

Statistics

Publications

8

Citations

465

H-Index

8

Active since

2015

Affiliations

Virginia Commonwealth University(Current)

Yale University

Amrita Sule is an author at Virginia Commonwealth University specializing in medicine, genome instability, and gene expression.

ORCID

Top concepts

Publications per year

2015–2022

8

Publications

8

The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models

Stephen T. Durant, Li Zheng, Yingchun Wang et al. · Science Advances · 2018 · 292 citations · Full text

Orally Bioavailable and Blood–Brain Barrier-Penetrating ATM Inhibitor (AZ32) Radiosensitizes Intracranial Gliomas in Mice

Jeremy Karlin, Jasmine Allen, Syed Farhan Ahmad et al. · Molecular Cancer Therapeutics · 2018 · 61 citations · Full text

Targeting IDH1/2 mutant cancers with combinations of ATR and PARP inhibitors

Amrita Sule, Jinny Van Doorn, Ranjini K. Sundaram et al. · NAR Cancer · 2021 · 31 citations · Full text

Mutation of the BRCA1 SQ-cluster results in aberrant mitosis, reduced homologous recombination, and a compensatory increase in non-homologous end joining

Jason M. Beckta, Seth M. Dever, Nisha Gnawali et al. · Oncotarget · 2015 · 26 citations · Full text

Mismatch repair proteins play a role in ATR activation upon temozolomide treatment in MGMT-methylated glioblastoma

Sachita Ganesa, Amrita Sule, Ranjini K. Sundaram et al. · Scientific Reports · 2022 · 22 citations · Full text

1–5 of 8